48 related articles for article (PubMed ID: 24036071)
1. Comparison of two self-sampling methods for human papillomavirus (HPV) DNA testing among women with high prevalence rates.
Kuriakose S; Sabeena S; Damodaran B; Ravishankar N; Ramachandran A; Ameen N
J Med Virol; 2020 Dec; 92(12):3884-3888. PubMed ID: 32436997
[TBL] [Abstract][Full Text] [Related]
2. HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
Pasquier C; Raymond S; Carcenac R; Demmou S; Ranger N; Nicot F; Izopet J
J Med Virol; 2024 May; 96(5):e29652. PubMed ID: 38727029
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.
Clifford GM; Vaccarella S; Franceschi S; Tenet V; Umulisa MC; Tshomo U; Dondog B; Vorsters A; Tommasino M; Heideman DA; Snijders PJ; Gheit T
J Clin Microbiol; 2016 Aug; 54(8):2031-8. PubMed ID: 27225411
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the FTA carrier device for human papillomavirus testing in developing countries.
Gonzalez P; Cortes B; Quint W; Kreimer AR; Porras C; Rodríguez AC; Jimenez S; Herrero R; Struijk L; Hildesheim A; Melchers W
J Clin Microbiol; 2012 Dec; 50(12):3870-6. PubMed ID: 22993174
[TBL] [Abstract][Full Text] [Related]
5. Establishment of immunoassay for detecting HPV16 E6 and E7 RNA.
Ding S; Qian SY; Zhang Y; Wu W; Lu G; Lu Y; Feng X; Li L; Shen P
Sci Rep; 2015 Sep; 5():13686. PubMed ID: 26333509
[TBL] [Abstract][Full Text] [Related]
6. Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
Downham L; Rol ML; Forestier M; Romero P; Mendoza L; Mongelós P; Picconi MA; Colucci MC; Padin VM; Flores AP; Zúñiga M; Ferrera A; Cabrera Y; Crispín MF; Ramirez AT; Cele L; Diop-Ndiaye H; Samaté D; Manga P; Thiam FB; Rodriguez MI; DSouza JP; Nyaga VN; Diop M; Sebitloane M; Sánchez GI; Teran C; Calderon A; Wiesner C; Murillo R; Herrero R; Baena A; Almonte M
Int J Cancer; 2024 Apr; ():. PubMed ID: 38602045
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus and blastocyst apoptosis.
Calinisan JH; Chan SR; King A; Chan PJ
J Assist Reprod Genet; 2002 Mar; 19(3):132-6. PubMed ID: 12005308
[TBL] [Abstract][Full Text] [Related]
8. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
10. Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples.
Munkhdelger J; Kim G; Wang HY; Lee D; Kim S; Choi Y; Choi E; Park S; Jin H; Park KH; Lee H
Exp Mol Pathol; 2014 Oct; 97(2):279-84. PubMed ID: 25102300
[TBL] [Abstract][Full Text] [Related]
11. E6/E7 mRNA Expression of the Most Prevalent High-Risk HPV Genotypes in Cervical Samples from Serbian Women.
Nikolic N; Basica B; Mandic A; Surla N; Gusman V; Medic D; Petrovic T; Strbac M; Petrovic V
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900061
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols.
Sharma B; Lakhanpal V; Singh K; Oberoi L; Bedi PK; Devi P
J Lab Physicians; 2022 Sep; 14(3):336-342. PubMed ID: 36119422
[No Abstract] [Full Text] [Related]
13. Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.
Iftner T; Wang L; Iftner A; Holz B; Haedicke-Jarboui J; Iftner N; von Wasielewski R; Martus P; Boehmer G
BMC Infect Dis; 2016 Nov; 16(1):672. PubMed ID: 27835974
[TBL] [Abstract][Full Text] [Related]
14. In North America, some ovarian cancers express the oncogenes of preventable human papillomavirus HPV-18.
Roos P; Orlando PA; Fagerstrom RM; Pepper JW
Sci Rep; 2015 Feb; 5():8645. PubMed ID: 25721614
[TBL] [Abstract][Full Text] [Related]
15. Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.
Salimović-Bešić I; Hukić M
Epidemiol Infect; 2015 Sep; 143(12):2604-12. PubMed ID: 25578155
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears.
Salimović-Bešić I; Tomić-Čiča A; Smailji A; Hukić M
J Virol Methods; 2013 Dec; 194(1-2):222-8. PubMed ID: 24036071
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
19. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.
Halfon P; Benmoura D; Agostini A; Khiri H; Martineau A; Penaranda G; Blanc B
J Clin Virol; 2010 Feb; 47(2):177-81. PubMed ID: 20022804
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
